Eli Lilly and Company (LLY)
Create an Alert
51.37
-0.98 -1.87%
NYSE
Jun 19, 8:00PM
BATS Real time
Currency in USD
Eli Lilly and Company Cash from Financing Quarterly:
-1.730B for March 31, 2013Eli Lilly and Company Historical Cash from Financing Quarterly Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| March 31, 2013 | -1.730B |
| Dec. 31, 2012 | -1.265B |
| Sept. 30, 2012 | -544.70M |
| June 30, 2012 | -552.70M |
| March 31, 2012 | -2.057B |
| Dec. 31, 2011 | -650.90M |
| Sept. 30, 2011 | -440.90M |
| June 30, 2011 | -564.30M |
| March 31, 2011 | -713.80M |
| Dec. 31, 2010 | -549.60M |
| Sept. 30, 2010 | -393.80M |
| June 30, 2010 | -531.50M |
| March 31, 2010 | -547.00M |
| Dec. 31, 2009 | -1.128B |
| Sept. 30, 2009 | -913.20M |
| June 30, 2009 | -1.112B |
| March 31, 2009 | -2.380B |
| Dec. 31, 2008 | 4.297B |
| Sept. 30, 2008 | -565.80M |
| June 30, 2008 | -523.50M |
| March 31, 2008 | Go Pro |
| Dec. 31, 2007 | Go Pro |
| Sept. 30, 2007 | Go Pro |
| June 30, 2007 | Go Pro |
| March 31, 2007 | Go Pro |
| Dec. 31, 2006 | Go Pro |
| Sept. 30, 2006 | Go Pro |
| June 30, 2006 | Go Pro |
| March 31, 2006 | Go Pro |
| Dec. 31, 2005 | Go Pro |
| Sept. 30, 2005 | Go Pro |
| June 30, 2005 | Go Pro |
| March 31, 2005 | Go Pro |
| Dec. 31, 2004 | Go Pro |
| Sept. 30, 2004 | Go Pro |
| June 30, 2004 | Go Pro |
| March 31, 2004 | Go Pro |
| Dec. 31, 2003 | Go Pro |
| Sept. 30, 2003 | Go Pro |
| June 30, 2003 | Go Pro |
| March 31, 2003 | Go Pro |
| Dec. 31, 2002 | Go Pro |
| Sept. 30, 2002 | Go Pro |
| June 30, 2002 | Go Pro |
| March 31, 2002 | Go Pro |
| Dec. 31, 2001 | Go Pro |
| Sept. 30, 2001 | Go Pro |
| June 30, 2001 | Go Pro |
| March 31, 2001 | Go Pro |
| Dec. 31, 2000 | Go Pro |
About Cash From Financing
An item on a company's cash flow statement. Lists aggregate change in cash position resulting from financing activities. Includes the company's cash inflows and outflows from issuing cash dividends, issuing and selling stock, and adding or changing loans.
Learn More
LLY Cash from Financing Quarterly Benchmarks
| Companies | |
|---|---|
| Pfizer | 434.00M |
| GlaxoSmithKline | -2.211B |
| Abbott Laboratories | -4.733B |
LLY Cash from Financing Quarterly Rankings
| Overall |
51st percentile 8176 of 16782 |
| Sector |
39th percentile 857 of 1410 in Healthcare |
| Industry |
54th percentile 62 of 135 in Drug Manufacturers - Major |
LLY Cash from Financing Quarterly Range, Past 5 Years
| Minimum | -2.380B | Mar 2009 |
| Maximum | 4.297B | Dec 2008 |
| Average | -643.37M |
